Desloratadine NDC 50090-4794

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-4794Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-4794Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-4794-0	50090479400	90 TABLET, FILM COATED in 1 BOTTLE (50090-4794-0)Marketed from Dec 12, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desloratadine
Generic name (nonproprietary): desloratadine
Active ingredients: Desloratadine — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078352
Marketing start: Feb 25, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 50090-4794_e682431d-3333-4fcb-8457-38b3e045b723SPL ID e682431d-3333-4fcb-8457-38b3e045b723SPL set ID 69b9635b-c790-4316-a790-67b0f5512b72RxCUI 349420UNII FVF865388R
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090479400 followed by a unit qualifier and the quantity

Package 50090-4794-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 16, 2026.

Indications (excerpt from the label)

Desloratadine tablets are histamine-1 (H1) receptor antagonist indicated for: Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. ( 1.1 ) Perennial Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. ( 1.2 ) 1.1 Seasonal Allergic Rhinitis Desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. 1.2 Perennial Allergic Rhinitis Desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078352

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078352
Product	Strength	Form · route	Labeler	Product NDC
Desloratadine	Desloratadine 5 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-6724
Desloratadine	Desloratadine 5 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1000
Desloratadine	Desloratadine 5 mg/1	Tablet, Film coatedOral	Lupin Pharmaceuticals, Inc.	68180-153